Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Enalaprilat
Drug ID BADD_D00768
Description Enalaprilat is the active metabolite of the orally available pro-drug, [enalapril]. Used in the treatment of hypertension, enalapril is an ACE inhibitor that prevents Angiotensin Converting Enzyme (ACE) from transforming angiotensin I into angiotensin II. As angiotensin II is responsible for vasoconstriction and sodium reabsorption in the proximal tubule of the kidney, down-regulation of this protein results in reduced blood pressure and blood fluid volume. Enalaprilat was originally created to overcome the limitations of the first ACE inhibitor, captopril, which had numerous side effects and left a metallic taste in the mouth. Removal of the problematic thiol group from captopril resulted in enalaprilat, which was then modified further with an ester to create the orally available pro-drug enalapril. Enalaprilat is poorly orally available and is therefore only available as an intravenous injection for the treatment of hypertension when oral therapy is not possible.
Indications and Usage Enalaprilat injection is indicated for the treatment of hypertension when oral therapy is not practical.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB09477
KEGG ID D03769
MeSH ID D015773
PubChem ID 5462501
TTD Drug ID D0N5HJ
NDC Product Code 51662-1477; 0143-9786; 43598-078; 71796-040; 43598-169; 0143-9787
UNII Q508Q118JM
Synonyms Enalaprilat | Enalaprilic Acid | Enalaprilat Dihydrate | Enalaprilat Citrate, Anhydrous | Enalaprilat, (R)-Isomer, Anhydrous | Pres iv | Vasotec | Enalaprilat Anhydrous | Xanef | 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate | MK-422 | MK 422 | MK422
Chemical Information
Molecular Formula C18H24N2O5
CAS Registry Number 76420-72-9
SMILES CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Transient ischaemic attack24.04.06.005; 17.08.04.0010.006079%
Upper gastrointestinal haemorrhage24.07.02.024; 07.12.02.0060.005065%
Upper respiratory tract infection11.01.13.009; 22.07.03.011--
Urinary retention20.02.02.0110.002026%
Urinary tract disorder20.08.01.0010.002026%Not Available
Urinary tract infection20.08.02.001; 11.01.14.004--
Urticaria23.04.02.001; 10.01.06.0010.022491%
Vascular purpura01.01.04.007; 24.07.06.011; 23.06.01.0080.002026%Not Available
Vasculitis24.12.04.027; 10.02.02.006--
Ventricular extrasystoles02.03.04.0070.003039%Not Available
Ventricular tachycardia02.03.04.0100.002026%
Vertigo17.02.12.002; 04.04.01.0030.007092%
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.0030.025327%
Mental status changes19.07.01.0010.006079%Not Available
Tubulointerstitial nephritis20.05.02.0020.003039%Not Available
Intracardiac thrombus02.11.01.017; 24.01.05.0030.002026%Not Available
Ischaemic cardiomyopathy02.04.01.004; 24.04.04.0190.004052%Not Available
Brain oedema12.01.10.010; 17.07.02.0030.002026%
Red blood cell sedimentation rate increased13.01.03.001--Not Available
Nocturnal dyspnoea22.02.01.019; 02.11.05.0090.002026%Not Available
Precancerous skin lesion23.01.06.0040.002026%Not Available
General physical health deterioration08.01.03.0180.006079%Not Available
Tachyarrhythmia02.03.02.0080.002026%Not Available
Idiosyncratic drug reaction08.06.01.0020.003039%Not Available
Dysstasia08.01.03.089; 17.02.02.012; 15.03.05.0110.002026%Not Available
Intervertebral disc protrusion15.10.01.0040.002026%Not Available
Blood pressure inadequately controlled24.06.01.0070.005471%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
The 10th Page    First    Pre   10 11 12    Next   Last    Total 12 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene